Publications

Diabetes and infectious disease mortality in Mexico City.

Bragg F. et al, (2023), BMJ open diabetes research & care, 11

Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK.

Zhou J. et al, (2023), Pharmacoeconomics

Mechanisms and Predictors of Acute Kidney Injury with Perioperative Rosuvastatin in Patients Undergoing Cardiac Surgery

Wijesurendra RS. et al, (2023)

Body Composition and Risk of Vascular-Metabolic Mortality Risk in 113 000 Mexican Men and Women Without Prior Chronic Disease.

Gnatiuc Friedrichs L. et al, (2023), J Am Heart Assoc

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials.

Nuffield Department of Population Health Renal Studies Group None. and SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium None., (2022), Lancet, 400, 1788 - 1801

Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes.

Nag A. et al, (2022), Sci Adv, 8

Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adults.

Aguilar-Ramirez D. et al, (2022), Commun Med (Lond), 2

Empagliflozin in Patients with Chronic Kidney Disease.

EMPA-KIDNEY Collaborative Group None. et al, (2022), N Engl J Med

Educational inequalities and premature mortality: the Cuba Prospective Study.

Ross S. et al, (2022), Lancet Public Health, 7, e923 - e931

Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19.

Sandercock PAG. et al, (2022), Trials, 23

Association Between Smoking, Smoking Cessation, and Mortality by Race, Ethnicity, and Sex Among US Adults.

Thomson B. et al, (2022), JAMA Netw Open, 5

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet, 400, 832 - 845

Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease: Insights From Genetic Epidemiology.

Staplin N. et al, (2022), Hypertension

Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials.

Pitcher A. et al, (2022), Lancet

Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes.

Akbari P. et al, (2022), Nat Commun, 13

Individual participant data meta-analysis of muscle symptoms in large-scale randomised double-blind trials of statin therapy

BAIGENT C. et al, (2022), The Lancet

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

RECOVERY Collaborative Group None., (2022), Lancet, 400, 359 - 368

Harmonisation of large-scale, heterogeneous individual participant adverse event data from randomised trials of statin therapy.

Cholesterol Treatment Trialists' Collaboration None., (2022), Clin Trials

Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry.

Bohbot Y. et al, (2022), European journal of heart failure, 24, 1253 - 1265

Genotyping, sequencing and analysis of 140,000 adults from the Mexico City Prospective Study

Ziyatdinov A. et al, (2022)

Cookies on this website

Publications